What:  Luncheon with the Experts presented by the Carcinoid Cancer Foundation

Who: Diane Reidy-Lagunes, MD is the featured guest

When: Thursday, July 7, 2022 from 12 noon to 1 pm, Eastern Time
Click on the orange date above to add the event to your calendar.
Where:  CCF’s Facebook Page, https://www.facebook.com/Carcinoid/. Just come to the page at noon and the program will begin. There is no need to register nor is there a special link.
For anyone not on Facebook, each of the presentations in the series is available on CCF’s YouTube channel, https://www.youtube.com/user/CarcinoidNETs. To receive notifications of all new videos on our YouTube channel, CLICK LIKE, SUBSCRIBE and HIT THE BELL to receive notifications each time a new video is uploaded.
Diane Reidy-Lagunes, MD, a medical oncologist, is Associate Deputy Physician-In-Chief, Regional Care Network; Physician Ambassador, Patient Family Advisory Council for Quality; and President, MSK Medical Staff at Memorial Sloan Kettering Cancer Center in New York City.

Dr. Reidy-Lagunes cares for people with gastrointestinal and endocrine cancers, including neuroendocrine, adrenal, colon, appendix, and pancreatic cancers, and cholangiocarcinoma. Her research is focused on finding methods to use a molecular-based approach to treat neuroendocrine and adrenocortical cancers.

Clinical trials for which Dr. Reidy-Lagunes is a co-investigator are:

-- A Phase I Study of 177Lu-DOTA-EB-TATE in People with Advanced Neuroendocrine Cancers

-- A Phase IB Study of Relacorilant and Pembrolizumab Immunotherapy for People with Adrenocortical Carcinoma that Produces Too Much Cortisol

-- A Phase II Study of Different Embolization Approaches to Treat Neuroendocrine Liver Metastases

-- A Phase II Study of Temozolomide and Olaparib to Treat Advanced Pheochromocytoma and Paraganglioma

-- A Phase III Study of Cabozantinib versus Placebo in Patients with Inoperable or Metastatic Pancreatic Neuroendocrine and Carcinoid Tumors

-- A Study Comparing Lutetium Edotreotide with Standard Treatments in People with Digestive Neuroendocrine Tumors
Viewers are welcome to pose questions for Dr. Reidy-Lagunes during the live program.
Manage your preferences | Opt out using TrueRemove™
Got this as a forward? Sign up to receive our future emails.
View this email online.
118 N. Bedford Road Suite 100
Mt. Kisco, NY | 10549-2555 US
This email was sent to .
To continue receiving our emails, add us to your address book.
powered by emma
Subscribe to our email list.